Tag: Stephen Van Deventer
November 13, 2018
PreveCeutical Announces LOI with Crushedit LLC to Supply CBD Isolate for Expected Sale Proceeds of $16.25 Million
PreveCeutical Medical Inc. (CSE:PREV, OTCQB:PRVCF, FSE:18H), (the "Company" or "PreveCeutical") announces that it has entered into a non-binding letter of intent dated November 9,... October 31, 2018
PreveCeutical Provides Update on Visit to Penta 5 Group’s Facility for Due Diligence on Proposed Acquisition
PreveCeutical Medical Inc. (CSE:PREV, OTCQB:PRVCF, FSE:18H) (the "Company" or "PreveCeutical"), provides an update on its recent due diligence trip (the "Due... October 30, 2018
PreveCeutical Holds Intensive Workshop to Advance Dual Gene Therapy Research Program for Type 2 Diabetes and Obesity
PreveCeutical Medical Inc. (CSE:PREV, OTCQB:PRVCF, FSE:18H) (the "Company" or "PreveCeutical"), is pleased to announce that its research team at the University of Queensland,... September 26, 2018
PreveCeutical Enters into Development Agreement with Asterion Cannabis Inc. to Develop Medicinal Cannabinoid Products
PreveCeutical Medical Inc. (CSE:PREV, OTCQB:PRVCF, FSE:18H) ("PreveCeutical"), and Asterion Cannabis Inc. ("Asterion") announce that they have entered into a development...
September 4, 2018
Asterion Enters Consulting Agreement with White Sheep Services Corp. and Appoints Hamish Sutherland as COO
Asterion Cannabis Inc. ("Asterion" or the "Company"), is pleased to announce that it has entered into a consulting agreement with...
August 22, 2018